Newcastle University
»
Leukaemia Research Cytogenetics Group
»
Our Projects
»
Selected Abstracts
» Intragenic Pax5 Amplification
Leukaemia Research Cytogenetics Group
Leukaemia Research Cytogenetics Group
Skip to content
Home
Our Projects
LRCG Specialist Programme (2016-2023)
Personalising Therapy for Adults with ALL(2016-22)
HARMONY (2017-23)
CLOSER (2019-24)
Overview of LRCG Research Programme
LRCG Group Research Network
Selected Abstracts
Intragenic Pax5 Amplification
Relapse Risk for iAMP21 Patients
UK Copy Number Alteration Classifier
Integrated Cytogenetic & Genomic Classification
LRCG in the News
Leadership Team
Publications
Funders
Contact
NU ALL PPI Panel
LRCG Specialist Programme (2016-2023)
Personalising Therapy for Adults with ALL(2016-22)
HARMONY (2017-23)
CLOSER (2019-24)
Overview of LRCG Research Programme
LRCG Group Research Network
Selected Abstracts
Intragenic Pax5 Amplification
Relapse Risk for iAMP21 Patients
UK Copy Number Alteration Classifier
Integrated Cytogenetic & Genomic Classification
LRCG in the News
Intragenic Pax5 Amplification
C Schwab et al
Blood Adv. 2017 Aug 22; 1(19): 1473–1477
.
Top
.jpg)
